Efficacy and Safety of Medical Abortion Using Mifepristone and Buccal Misoprostol Through 63 Days

Contraception - United States
doi 10.1016/j.contraception.2015.01.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effectiveness of Medical Abortion With Mifepristone and Buccal Misoprostol Through 59 Gestational Days

Contraception
GynecologyReproductive MedicineObstetrics
2009English

Safety, Efficacy and Acceptability of Mifepristone-Misoprostol Medical Abortion in Vietnam

International Family Planning Perspectives
1999English

Medical Abortion in Early Pregnancy by Oral Mifepristone and Oral Misoprostol

IOSR Journal of Dental and Medical Sciences
2017English

Domicilliary Use of Oral Mifepristone and Misoprostol in First Trimester Medical Abortion

Journal of Medical Science And clinical Research
2018English

Practice of Self-Medication of Mifepristone-Misoprostol Drug Combination for Medical Abortion

International Journal of Basic & Clinical Pharmacology
2014English

SECOND TRIMESTER ABORTION: MIFEPRISTONE PLUS MISOPROSTOL vs. MISOPROSTOL PLUS OXYTOCIN

Farmacia
ToxicologyPharmaceuticsPharmacology
2019English

Low Dose Mifepristone and Vaginal Misoprostol: A Safe Option for Termination of Pregnancy Up to 63 Days

Internet Journal of Gynecology and Obstetrics
GynecologyObstetrics
2007English

Comparison of Efficacy of Buccal Versus Vaginal Misoprostol in First Trimester Induced Abortion

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

Mifepristone and Misoprostol Administered Simultaneously Versus 24 Hours Apart for Abortion

Obstetrics and Gynecology
GynecologyObstetrics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy